Insiders Supernus Pharmaceuticals, Inc.

Equities

Market Closed - Nasdaq Other stock markets 04:00:00 2024-06-10 pm EDT			5-day change	1st Jan Change
26.19 ^USD	-0.27%		-5.14%	-9.50%

May. 23	Supernus Pharmaceuticals Reports 'Clinical Utility' From Epilepsy Treatment Study	MT
May. 23	Transcript : Supernus Pharmaceuticals, Inc. - Special Call

Supernus Pharmaceuticals, Inc. Announces Retirement of John M. Siebert from the Board of Directors	Apr. 24	CI
Supernus Pharmaceuticals Insider Sold Shares Worth $511,677, According to a Recent SEC Filing	Mar. 25	MT
Supernus Pharmaceuticals Insider Sold Shares Worth $436,573, According to a Recent SEC Filing	Mar. 21	MT
Supernus Pharmaceuticals, Inc. Announces Executive Changes	Feb. 21	CI
Supernus Pharmaceuticals Insider Sold Shares Worth $259,151, According to a Recent SEC Filing	Nov. 17	MT
Insider Sell: Supernus Pharmaceuticals	23-09-01	MT
Insider Sell: Supernus Pharmaceuticals	23-08-29	MT
Supernus Pharmaceuticals, Inc. Appoints Bethany L. Sensenig to Board of Directors	23-08-21	CI
Insider Sell: Supernus Pharmaceuticals	23-03-16	MT
Insider Sell: Supernus Pharmaceuticals	23-02-06	MT
Insider Sell: Supernus Pharmaceuticals	23-01-20	MT
Insider Sell: Supernus Pharmaceuticals	23-01-19	MT
Insider Sell: Supernus Pharmaceuticals	23-01-19	MT
Insider Sell: Supernus Pharmaceuticals	22-12-22	MT
Insider Sell: Supernus Pharmaceuticals	22-12-02	MT
Insider Sell: Supernus Pharmaceuticals	22-11-15	MT
Insider Sell: Supernus Pharmaceuticals	22-08-23	MT
Insider Sell: Supernus Pharmaceuticals	22-08-18	MT
Insider Sell: Supernus Pharmaceuticals	22-08-17	MT
Insider Sell: Supernus Pharmaceuticals	22-08-11	MT

No results for this search